Made in Italy

We seek to improve people's health& life quality
through innovation, because we care.

Bang Nanobiotech s.r.l is founded in 2020.

To avoid side effects and pains from oral administration & injections,based on the 1st-time research breakthrough in last 30 years, we’ve developed an innovative dressing  BanGel, a versatile transdermal drug delivery platform, which can broadly expand the possibility of transdermal drug categories,
 solve all the limitations of other transdermal solutions, and maximize the value of transdermal drug delivery, providing for the patients an easy, smart, and efficient therapy!

Improving transdermal solutions existed

The limitations of transdermal drug delivery solutions in the market are low drug loading and release efficiency, inferior durability, and short curative period, like plaster, cream, gel, and other hydrogel.

Expanding the possibility of transdermal drug categories

With all-in-one features, BanGel is able to unlock the high potential of the Transdermal Drug Delivery System and expand the Madeline categories that can be delivered via skin.

Other outstanding material capabilities

Waterproof, elongation, durability, skin affinity, limited costs, biodegradability

BanGel challenges loading of unstable, oxidizable, and heat-sensitive active ingredients.


Moisturizing Anti-aging Whitening Lifting

Breakthrough technology

0% Preservative 0% Thickener 0% addictive

Yunsong Yan

Co-Founder, CEO&CTO

Ph.D Dr.Yan has been the Chief Executive Officer and Chief Technical Officer since its foundation in 2020. His role on the team consists of commercial management, general administration, and R&D.

Read More  

Xueting Bai

Co-Founder, CTO

Ph.D Dr.Bai has been the Chief Technical Officer since its foundation in 2020. Her role on the team consists of R&D product development in pharmacology, especially for the product in preclinical and clinical research.

Read More  

Leonardo Qiu

Co-Founder, COO

Mr. Qiu mainly focuses on the day-to-day operations and investor relationship management in Bang Nanobiotech s.r.l.

Read More  

Linru Cai

Co-Founder, CMO

Mrs Cai is one of the co-founders and is currently the Chief Marketing Officer of Bang Nanobiotech s.r.l.

Read More  

Sheng Xu

Co-Founder, CSO

Mr. Xu is responsible for the corporate strategy definition & implementation, and overall organizational & governance process design and implementation in Bang Nanobiotech.

Read More  

Our startup has been selected for the next phase of the BIND 4.0 Open Innovation & Acceleration program Selection process.

  •  27/09/2022 03:25 PM

Bang Nanobiotech developed an innovative dressing material in Wound Care, which is the first-time breakthrough in the past 30 years and gives a life-changing experience to patients.

  •  01/10/2021 12:00 AM
​​​​​​​​We welcome inquiries from potential new investors and partners as we raise funds to support the development and commercialization of processes and products. Currently, Bang Nanobiotech s.r.l.’s funding is from business angels and private investors, as well as the EU’s research and innovation program.
A robust business plan and promising projections underpin an exciting financial opportunity to work with us in the launching stages. Our phased plan offers the potential for a high return on investment. The board of directors, leading advisory team, partners and investors are highly respected in field of respective materials and venture capital industries. With the help of passionate support, advice, and guidance from them, Bang Nanobiotech s.r.l becomes a promising company owning several patented biomedical products and nanotechnologies. These patents further underscore the terrific potential of our technology in changing the face of the biomedical materials market.
  • Viale Ortles, 22/4, 20139, Milano, MI, Italia